الملخص
بيانات النشر
- المعرّف الرقمي
- 10.4103/0974-620x.71911
- المجلة
- المجلة العُمانية لطب العيون, 3(3), 159-160
- الناشر
- منشورات ميدنو
- وصول مفتوح
- وصول مفتوح ذهبي
اقتبس هذه المقالة
APA 7
Chhablani, J. K. (2010). Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization. Oman Journal of Ophthalmology, 3(3), 159-160. https://doi.org/10.4103/0974-620x.71911
MLA 9
Chhablani, Jay Kumar. "Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization." Oman Journal of Ophthalmology, vol. 3, no. 3, 2010, pp. 159-160. https://doi.org/10.4103/0974-620x.71911.
شيكاغو (المؤلف–التاريخ)
Chhablani, Jay Kumar. 2010. "Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization." Oman Journal of Ophthalmology 3 (3): 159-160. https://doi.org/10.4103/0974-620x.71911.
هارفارد
Chhablani, J. K. (2010) 'Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization', Oman Journal of Ophthalmology, 3(3), pp. 159-160. doi:10.4103/0974-620x.71911.
فانكوفر
Chhablani JK. Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization. Oman Journal of Ophthalmology. 2010;3(3):159-160. doi:10.4103/0974-620x.71911
IEEE
J. K. Chhablani, "Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization," Oman Journal of Ophthalmology, vol. 3, no. 3, pp. 159-160, 2010, doi: 10.4103/0974-620x.71911.